Literature DB >> 32925832

American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic.

Elliott D Kozin1,2, Aaron K Remenschneider1,2,3, Nikolas H Blevins4, Taha A Jan4, Alicia M Quesnel1,2, Divya A Chari1,2, Bradley W Kesser5, Jaqueline E Weinstein6, Syed F Ahsan7,8, Fred F Telischi9, Oliver F Adunka10, Peter Weber11, Renata M Knoll2, Daniel H Coelho12, Samantha Anne13, Kevin H Franck1,14, Daniele Marchioni15, Frederick G Barker16, Bob S Carter16, Lawrence R Lustig17,18, Dennis I Bojrab19, Sanjay A Bhansali20, Brian D Westerberg21, Larry Lundy22, Robert K Jackler3, J Thomas Roland23, Sujana S Chandrasekhar24,25,26, Patrick J Antonelli27, John P Carey28, D Bradley Welling1,2, William H Slattery29, Daniel J Lee1,2.   

Abstract

: This combined American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Surgery Foundation document aims to provide guidance during the coronavirus disease of 2019 (COVID-19) on 1) "priority" of care for otologic and neurotologic patients in the office and operating room, and 2) optimal utilization of personal protective equipment. Given the paucity of evidence to inform otologic and neurotologic best practices during COVID-19, the recommendations herein are based on relevant peer-reviewed articles, the Centers for Disease Control and Prevention COVID-19 guidelines, United States and international hospital policies, and expert opinion. The suggestions presented here are not meant to be definitive, and best practices will undoubtedly change with increasing knowledge and high-quality data related to COVID-19. Interpretation of this guidance document is dependent on local factors including prevalence of COVID-19 in the surgeons' local community. This is not intended to set a standard of care, and should not supersede the clinician's best judgement when managing specific clinical concerns and/or regional conditions.Access to otologic and neurotologic care during and after the COVID-19 pandemic is dependent upon adequate protection of physicians, audiologists, and ancillary support staff. Otolaryngologists and associated staff are at high risk for COVID-19 disease transmission based on close contact with mucosal surfaces of the upper aerodigestive tract during diagnostic evaluation and therapeutic procedures. While many otologic and neurotologic conditions are not imminently life threatening, they have a major impact on communication, daily functioning, and quality of life. In addition, progression of disease and delay in treatment can result in cranial nerve deficits, intracranial and life-threatening complications, and/or irreversible consequences. In this regard, many otologic and neurotologic conditions should rightfully be considered "urgent," and almost all require timely attention to permit optimal outcomes. It is reasonable to proceed with otologic and neurotologic clinic visits and operative cases based on input from expert opinion of otologic care providers, clinic/hospital administration, infection prevention and control specialists, and local and state public health leaders. Significant regional variations in COVID-19 prevalence exist; therefore, physicians working with local municipalities are best suited to make determinations on the appropriateness and timing of otologic and neurotologic care.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32925832     DOI: 10.1097/MAO.0000000000002868

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  8 in total

1.  Is 2020 the golden year of Otolaryngology research? The impact of COVID-19 on the Italian academic production.

Authors:  Eleonora Trecca; Pier Gerardo Marano; Matteo Gelardi; Lazzaro Cassano; Giannandrea Francesco Verzicco; Aurelio D'Ecclesia; Michele Cassano; Francesco Longo
Journal:  Acta Biomed       Date:  2021-05-12

2.  How great is the negative impact of masking and social distancing and how can we enhance communication skills in the elderly people?

Authors:  Davide Brotto; Flavia Sorrentino; Anna Agostinelli; Elisa Lovo; Silvia Montino; Patrizia Trevisi; Niccolò Favaretto; Roberto Bovo; Alessandro Martini
Journal:  Aging Clin Exp Res       Date:  2021-03-16       Impact factor: 3.636

3.  Undetectable viral load within the mastoid during cochlear implantation in a patient with COVID-19.

Authors:  Kyle S Kimura; Miriam R Smetak; Michael H Freeman; Christopher T Wootten
Journal:  Otolaryngol Case Rep       Date:  2021-03-02

Review 4.  Managing head and neck cancer patients during the COVID-19 pandemic: the experience of a tertiary referral center in southern Italy.

Authors:  Francesco Longo; Eleonora M C Trecca; Aurelio D'Ecclesia; Chiara Copelli; Karim Tewfik; Alfonso Manfuso; Nicola Pederneschi; Annalisa Mastromatteo; Matteo Aldo Russo; Antonio Pansini; Luca M Lacerenza; Pier Gerardo Marano; Lazzaro Cassano
Journal:  Infect Agent Cancer       Date:  2021-02-05       Impact factor: 2.965

Review 5.  Otitis Media Practice During the COVID-19 Pandemic.

Authors:  Tal Marom; Jacob Pitaro; Udayan K Shah; Sara Torretta; Paola Marchisio; Ayan T Kumar; Patrick C Barth; Sharon Ovnat Tamir
Journal:  Front Cell Infect Microbiol       Date:  2022-01-07       Impact factor: 5.293

6.  COVID-19 and otologic surgery.

Authors:  Donald Tan; Kristen L Yancey; Jacob B Hunter
Journal:  Oper Tech Otolayngol Head Neck Surg       Date:  2022-04-28

7.  Otolaryngology in the face of A pandemic.

Authors:  Nicole Ruszkay; Jacqueline Tucker; Karen Y Choi
Journal:  Oper Tech Otolayngol Head Neck Surg       Date:  2022-04-28

8.  A multicenter study to investigate the positive rate of SARS-CoV-2 in middle ear and mastoid specimens from otologic surgery patients.

Authors:  Hiroshi Yamazaki; Norio Yamamoto; Toru Sonoyama; Hayato Maruoka; Seiko Nasu; Akiko Makino; Keizo Tomonaga; Norifumi Shigemoto; Hiroki Ohge; Keizo Fujiwara; Shogo Shinohara; Sachio Takeno; Koichi Omori; Yasushi Naito
Journal:  Auris Nasus Larynx       Date:  2022-07-29       Impact factor: 2.119

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.